US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Articles published by Onco-Innovations Limited

News headline image
Onco-Innovations Enters into LOI with Ifowonco for Exclusive Option and Worldwide Licence to LAG-3 Small-Molecule Inhibitor Program
From Onco-Innovations Limited
Via ACCESS Newswire
Tickers ONNVF
News headline image
Onco-Innovations Completes Analytical Reference Standard Preparation Program for ONC010’s API
From Onco-Innovations Limited
Via ACCESS Newswire
Tickers ONNVF
News headline image
Onco-Innovations Announces Term Sheet for Notional CAD$5 Million Performance-Based Funding Arrangement and Amendments to Previously Announced Financing
From Onco-Innovations Limited
Via ACCESS Newswire
Tickers ONNVF
News headline image
Onco-Innovations Initiates Polymer Process Development and Characterization Program for ONC010
From Onco-Innovations Limited
Via ACCESS Newswire
Tickers ONNVF
News headline image
Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
From Onco-Innovations Limited
Via ACCESS Newswire
Tickers ONNVF
News headline image
Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Leading Out in Developing Fresh Wave of Inhibitor Classes
From Onco-Innovations Limited
Via GlobeNewswire
Tickers ONNVF
News headline image
Onco-Innovations Engages Nanosoft Polymers to Advance Polymer and Drug Delivery Development for ONC010
From Onco-Innovations Limited
Via ACCESS Newswire
Tickers ONNVF
News headline image
Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Advancing Nanoparticle-Encapsulated PNKP Inhibitor in Oncology Space
From Onco-Innovations Limited
Via GlobeNewswire
Tickers ONNVF
News headline image
Onco-Innovations Announces Non-Brokered LIFE Offering
From Onco-Innovations Limited
Via ACCESS Newswire
Tickers ONNVF
News headline image
Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
From Onco-Innovations Limited
Via ACCESS Newswire
Tickers ONNVF
News headline image
Onco-Innovations Completes Project with Kuano, Using Their Quantum-Based Platform to Deliver Insights for PNKP Inhibitor Technology Optimization
From Onco-Innovations Limited
Via ACCESS Newswire
Tickers ONNVF